Caroline Even
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Caroline Even has a total of 90 co-authors. Here are the top co-authors by number of shared publications:
- Athénaïs van der Elst
Pôle oncologie, Institut de Recherche Clinique et Expérimentale, Université catholique de Louvain (UCLouvain), Brussels, Belgium
34 shared publications - Bernd Bodenmiller
Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland
34 shared publications - Céline Lefebvre
IMMUcan Consortium, Brussels, Belgium
34 shared publications - Daniel Herrero-Saboya
IMMUcan Consortium, Brussels, Belgium
34 shared publications - Daniel Schulz
Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland
34 shared publications - Henoch Sangjoon Hong
IMMUcan Consortium, Brussels, Belgium
34 shared publications
Latest Publications
- Open Access
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1-S8 from HPV16 Genomic Status Stratifies Risk of Disease Recurrence in Oropharyngeal Squamous Cell Carcinoma
Supplementary Figure S1-S8 from HPV16 Genomic Status Stratifies Risk of Disease Recurrence in Oropharyngeal Squamous Cell Carcinoma
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1-S8 from HPV16 Genomic Status Stratifies Risk of Disease Recurrence in Oropharyngeal Squamous Cell Carcinoma
Supplementary Figure S1-S8 from HPV16 Genomic Status Stratifies Risk of Disease Recurrence in Oropharyngeal Squamous Cell Carcinoma
- Open Access
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from HPV16 Genomic Status Stratifies Risk of Disease Recurrence in Oropharyngeal Squamous Cell Carcinoma
Definition of viral genomic status groups
- 1 October 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from HPV16 Genomic Status Stratifies Risk of Disease Recurrence in Oropharyngeal Squamous Cell Carcinoma
Definition of viral genomic status groups
- Open Access
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S2. Study workflow and multi-omics approach
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S2. Study workflow and multi-omics approach
- Open Access
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S10 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S10. p-EMT and TLS signatures are prognostic factors in R/M SCCHN
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S10 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S10. p-EMT and TLS signatures are prognostic factors in R/M SCCHN
- Open Access
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S3. Three multiplex immunofluorescent staining of SCCHN samples with 3 different 6-plex panels and their deconvolution
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S3. Three multiplex immunofluorescent staining of SCCHN samples with 3 different 6-plex panels and their deconvolution
- Open Access
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S6. Genomic and transcriptomic alterations linked to HPV status
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S6 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S6. Genomic and transcriptomic alterations linked to HPV status
- Open Access
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S4. FFPE vs frozen tumor biopsies comparisons
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S4. FFPE vs frozen tumor biopsies comparisons